TAT 2013

-

TAT, a leading oncology phase 1 meeting

TAT 2013, Paris, March 4-6 , 2013, will be the next meeting in the unique series "International Congress on Targeted Anticancer Therapies" (TAT), which is devoted to the most promising new molecularly-targeted cancer therapeutics. TAT meetings are leading oncology phase 1 meetings in Europe and a must-attend for clinical investigators, research scientists and drug development professionals in pharma, biotech and CROs:

• Focus on promising new agents and molecular targets that are - or soon will be - in phase 1 clinical study
• Clinical and translational research discussed extensively
• Educational introductions of target biology help "newcomers" understand the science behind new targets
• Excellent opportunities for young investigators to present for the first time in their career in a comfortable and overseeable setting
• Many of the world's leading phase 1 groups represented


Location:
Marriott Rive Gauche Hotel & Conference Center
France


Organizer: Congress by Design

4 Mar 2013

Upcoming Featured Events
1 Next 
SLAS20174 Feb 2017
Pittcon Conference and Expo 20175 Mar 2017
AACR Annual Meeting 20171 Apr 2017
65th ASMS Conference4 Jun 2017



Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement